Document is current
Any future updates will be listed below
-
Authors
Daetwyler, Eveline
Jauch, Annaïse
Aeschlimann, Núria
Rommers, Nikki
Kasenda, Benjamin
Zippelius, Alfred
Kuster, Gabriela M. https://orcid.org/0000-0002-8209-4631
-
Funding
Funding for this research was provided by:
University of Basel
- License Information
-
More Information
Article History
Received: 4 February 2025
Accepted: 19 June 2026
First Online: 27 June 2026
Declarations
:
: The study was approved by the Ethics Committee of Northwestern and Central Switzerland (2023–00832) and conducted in accordance with the principles of the Declaration of Helsinki. All participants signed the general research consent, which is a type of informed consent that allows the use of health-related data for future unspecified research.
: Not applicable.
: ED, AJ, NAe, NR: none.BK received grants from Dayton Therapeutics, PharmaAnd as well as payments/honoraria for lectures, presentations/educational events and manuscript writing from Incyte and Roche, all outside of this work and paid to the institution.AZ received consulting/advisor fees from Bristol-Myers Squibb, Merck Sharp & Dohme, Hoffmann–La Roche, NBE Therapeutics, Engimmune, and maintains further non-commercial research agreements with Roche, Vectorbiopharma, T3 Pharma, AstraZeneca and Bright Peak Therapeutics, all outside of this work and paid to the institution.GMK received speaker and consulting/advisor fees from Janssen and consulting/advisor fees from PAGE Therapeutics, all outside of this work and paid to the institution.
